Get startedLog in
    Picture of Vector Science and Therapeutics logo

    PAIN — Vector Science and Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    FinancialsSpeculativeSmall CapMomentum Trap
    All News

    Brief: Vector Science And Therapeutics Enters Option To Buy Up To 15% Of Lyogenesis Plus For Up To $1 Million

    Picture of Vector Science and Therapeutics logoVector Science and Therapeutics
    13/05/2026 18:05
    May 13 (Reuters) - Vector Science and Therapeutics Corp PAIN.V:

VECTOR SCIENCE  THERAPEUTICS AGREES TO AN OPTION TO INVEST IN LYOGENESIS PLUS, SECURING LONG-TERM ACCESS TO FDA-REGISTERED, CGMP MANUFACTURING

VECTOR SCIENCE AND THERAPEUTICS CORP - ENTERS OPTION TO BUY UP TO 15% OF LYOGENESIS PLUS FOR UP TO $1 MILLION

Source text: ID:nPn51Bkr1a

Further company coverage: PAIN.V

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Vector Science and Therapeutics

    See all news